Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
Merck
Dow
McKinsey

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Profile for Australia Patent: 2009223108

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Australia Patent: 2009223108

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
  Start Trial Sep 21, 2020 Abbvie TRICOR fenofibrate
  Start Trial Sep 21, 2020 Endo Pharms Inc MEGACE ES megestrol acetate
  Start Trial Feb 21, 2023 Abbvie TRICOR fenofibrate
  Start Trial Feb 21, 2023 Abbvie TRICOR fenofibrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Colorcon
Medtronic
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.